Massimo Fiandaca

Massimo Fiandaca is a seasoned executive in the biotech sector, currently serving as Executive Vice President of Therapeutic Strategies at Asklepios BioPharmaceutical, Inc. since December 2020. With extensive experience in entrepreneurial endeavors and strategic development, Massimo possesses a strong background in neurological surgery and neuroscience research. Prior roles include leadership positions at Brain Neurotherapy Bio, Inc., and significant academic appointments at top institutions such as the University of California, San Francisco, UC Irvine, and Georgetown University Medical Center. Massimo has contributed to clinical and preclinical research in neurosurgery, gene therapy for neurodegenerative diseases, and the advancement of brain therapeutic delivery systems. Additionally, Massimo holds an MBA and has been involved in various editorial and leadership roles within professional organizations.